CFO, Chief Accounting Officer, Board Member
2022-01-01–present
Chief Accounting Officer
Cadrenal Therapeutics, Inc. (CVKD)Board Member
Cadrenal Therapeutics, Inc. (CVKD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2026-05-28–present
2026-05-28–present
2022-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CFO, Chief Accounting Officer, Board Member
2022-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cadrenal Therapeutics, Inc. (CVKD) | Chief Executive Officer | $751,275 | $1,909,694 |
| 2024 | Cadrenal Therapeutics, Inc. (CVKD) | Chief Executive Officer | $708,750 | $1,223,381 |
| 2023 | Cadrenal Therapeutics, Inc. (CVKD) | Chief Executive Officer | $662,500 | $967,000 |
Earnings-call appearances and filed executive appointments or departures, newest first.